Skip to content

Public FDA record

Z-2069-2012: IMPAX CV Reporting The Results Management (RM)/IMPAX CV reporting component facilitates the quick, eff

Recall record Z-2069-2012 for AGFA Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2069-2012
Company in FDA record
AGFA Corp.
FDA classification date
Jul 24, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

When users selected "Left stenosis" in the "Graft Duplex Conclusion" section in IMPAX CV Reporting Non-Invasive(NIV) module, "Right stenosis" appeared in the sentence display within the printed representation of the report.

Source facts

Action
AGFA Healthcare sent an Urgent Field Safety Notice dated July 10, 2012, to all affected consignees indicating that a representative from the IMPAX CV product management or professional services team would be contacting them to perform a review of their system. For questions customers were asked to call 401-604-2180. For questions regarding this recall call 864-421-1754.
Initiated
2012-07-10
Root cause
Error in labeling
Terminated
2013-10-29
Distribution
Nationwide Distribution including IN, SC, OH, TX
Recall number
Z-2069-2012
Recall status
Terminated
CDRH record ID
110871
FDA classified
2012-07-24
Recall event number
62534

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗